Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
seattle blog main
seattle top stories
28
×
startups
28
×
life sciences
san diego blog main
boston blog main
deals
detroit blog main
detroit top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco blog main
san francisco top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston top stories
national
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
fda
cancer
cancer immunotherapy
clinical trials
alzheimer's disease
eli lilly
novartis
vc
investing
medical devices
pfizer
What
roundup
bio
drug
based
seattle
companies
week
cancer
developing
drugs
medical
raised
acquisitions
alzheimer’s
biotech
capital
ceo
develop
fda
health
life
month
nash
new
news
patients
pfizer’s
pharmaceutical
sciences
seen
software
startup
technology
venture
year
ahead
amid
announced
annual
asco
Language
unset
unknown
Current search:
startups
×
" seattle top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Seattle’s TransformativeMed Carves Out Niche in Medical Specialties
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com
5 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
@xconomy.com
5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com
5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Providence St. Joseph Acquires Seattle Blockchain Startup Lumedic
@xconomy.com
5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Sentinel Healthcare Raises $2M For Hypertension-Monitoring Software
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More